Mesoblast Limited (ASX:MSB)
Australia · Delayed Price · Currency is AUD 2.710
+0.020 (0.74%)
At close: Nov 28, 2025
Mesoblast Market Cap
Mesoblast has a market cap or net worth of 3.48 billion as of November 28, 2025. Its market cap has increased by 71.15% in one year.
Market Cap
3.48B
Enterprise Value
3.43B
Revenue
26.23M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.71
Market Cap Chart
Since December 16, 2004, Mesoblast's market cap has increased from 76.57M to 3.48B, an increase of 4,440.74%. That is a compound annual growth rate of 19.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 3.48B | -2.16% |
| Dec 31, 2024 | 3.55B | 1,029.56% |
| Dec 29, 2023 | 314.59M | -50.91% |
| Dec 30, 2022 | 640.82M | -29.87% |
| Dec 31, 2021 | 913.81M | -30.79% |
| Dec 31, 2020 | 1.32B | 19.05% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 89.91B |
| Pro Medicus | 27.87B |
| Cochlear | 18.34B |
| Sonic Healthcare | 11.54B |
| Ramsay Health Care | 8.34B |
| Ansell | 5.37B |
| Telix Pharmaceuticals | 5.18B |
| Neuren Pharmaceuticals | 2.42B |